from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1407/fmu

LFCtreatmentdescriptionclass of inhibitor

-0.521

Amikacinug/mL Amikacintranslation

-0.847

Cap5-10ug/mL Capreomycintranslation

-0.666

Rox10-50 ug/mL Roxithromycintranslation

0.198

SM2-5 ug/mL Streptomycintranslation

-1.277

Tet5-10 ug/mL Tetracyclinetranslation

0.394

Rif0.2-5ug/mL Rifampicintranscription

-0.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.564

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.325

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.168

CPZ10-50 ug/mL Chlorpromazinerespiration

1.735

Clofazimine10-13 ug/mL Clofaziminerespiration

0.836

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.321

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.011

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.374

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.772

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.790

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.115

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.435

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.511

KCN5-20 ug/mL Potassium cyaniderespiration

0.111

NaN30.2-2 mM Sodium aziderespiration

-0.268

Nigericin50 uM Nigericinrespiration

0.677

TRC10-150 ug/mL Triclosanrespiration

-2.074

TRZ10-25 ug/mL Thioridazinerespiration

-0.453

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.141

menadione6-10 ug/mL Menadionerespiration

0.292

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.002

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.152

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.956

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.189

NRP_1Non-replicating persistence stage 1dosRassociated

-0.789

Amp0.2mg/mL AmpicillincellWall

0.485

Cephalexin20-100 ug/mL CephalexincellWall

0.071

Cerulenin0.32-5 ug/mL CerulenincellWall

0.006

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.059

EMB10-20 ug/mL EthambutolcellWall

0.174

Eta12-40 ug/mL EthionamidecellWall

0.258

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.030

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.099

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.425

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.140

BZA0.12 mg/mL BenzamidearomaticAmides

0.124

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.056

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.416

H2O24 mM hydrogen peroxideDNAdamaging

-0.056

Levo10 ug/mL LevofloxacinDNAdamaging

-0.634

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.518

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.109

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.475

UVUV-irradiationDNAdamaging

-0.504

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.600

Antimycin12.5-50 ug/mL Antimycin A?

-0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.306

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.377

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.849

PA8240.2-2 ug/mL PA-824?

0.224

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.867

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.268

Verapamil50 uM Verapamil?

-0.510

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.473

methoxatin10-20 ug/mL Methoxatin?